A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries.
source https://www.sciencedaily.com/releases/2021/06/210618134107.htm
Sunday, 20 June 2021
Related Posts
Minutes matter: Policies to improve care for deadliest heart attacks
COVID testing using pooled samples showed high accuracy, low cost
Longstanding magnetic materials classification problem solved
Data continues to show that American’s need at least 5 hours per week of physical activity to prevent some cancers
Lone changer: Fish camouflage better without friends nearby
Telehealth addiction treatment rose rapidly during pandemic; but potential benefits still unclear
0 comments: